61 related articles for article (PubMed ID: 4662739)
1. [The effect of the heterogeneity of the phantom on the distribution of the absorbed dose during local irradiation with a proton beam].
Voronin IuV
Med Radiol (Mosk); 1972 Oct; 17(10):67-70. PubMed ID: 4662739
[No Abstract] [Full Text] [Related]
2. Comparative treatment planning on localized prostate carcinoma conformal photon- versus proton-based radiotherapy.
Mock U; Bogner J; Georg D; Auberger T; Pötter R
Strahlenther Onkol; 2005 Jul; 181(7):448-55. PubMed ID: 15995838
[TBL] [Abstract][Full Text] [Related]
3. A review of the impact of photon and proton external beam radiotherapy treatment modalities on the dose distribution in field and out-of-field; implications for the long-term morbidity of cancer survivors.
Palm A; Johansson KA
Acta Oncol; 2007; 46(4):462-73. PubMed ID: 17497313
[TBL] [Abstract][Full Text] [Related]
4. [The dose field created by a proton beam in an irradiated body].
Vaĭnberg MSh; Dmitrievskiĭ IM; Semenov IuV; Telkov IuN; Frolov VV; Sharapov BN; Astrakhan BV; Salamov RF
Med Radiol (Mosk); 1970 May; 15(5):69-73. PubMed ID: 4988996
[No Abstract] [Full Text] [Related]
5. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
6. [Dose field formation on proton beam accelerator ITEF].
Blokhin SI; Gol'din LL; Kleĭnbok IaL; Lomanov MF; Onosovskiĭ KK; Pavlonskiĭ LM; Khoroshkov VS
Med Radiol (Mosk); 1970 May; 15(5):64-8. PubMed ID: 4988995
[No Abstract] [Full Text] [Related]
7. Comparison between in-beam and offline positron emission tomography imaging of proton and carbon ion therapeutic irradiation at synchrotron- and cyclotron-based facilities.
Parodi K; Bortfeld T; Haberer T
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):945-56. PubMed ID: 18514787
[TBL] [Abstract][Full Text] [Related]
8. Intrafractional motion during proton beam scanning.
Lambert J; Suchowerska N; McKenzie DR; Jackson M
Phys Med Biol; 2005 Oct; 50(20):4853-62. PubMed ID: 16204877
[TBL] [Abstract][Full Text] [Related]
9. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
[TBL] [Abstract][Full Text] [Related]
10. Dosimetry of clinical neutron and proton beams: an overview of recommendations.
Vynckier S; ;
Radiat Prot Dosimetry; 2004; 110(1-4):565-72. PubMed ID: 15353710
[TBL] [Abstract][Full Text] [Related]
11. Secondary neutron doses for several beam configurations for proton therapy.
Shin D; Yoon M; Kwak J; Shin J; Lee SB; Park SY; Park S; Kim DY; Cho KH
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):260-5. PubMed ID: 19362245
[TBL] [Abstract][Full Text] [Related]
12. A particle track-repeating algorithm for proton beam dose calculation.
Li JS; Shahine B; Fourkal E; Ma CM
Phys Med Biol; 2005 Mar; 50(5):1001-10. PubMed ID: 15798272
[TBL] [Abstract][Full Text] [Related]
13. Dynamic splitting of Gaussian pencil beams in heterogeneity-correction algorithms for radiotherapy with heavy charged particles.
Kanematsu N; Komori M; Yonai S; Ishizaki A
Phys Med Biol; 2009 Apr; 54(7):2015-27. PubMed ID: 19287085
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo investigation of collimator scatter of proton-therapy beams produced using the passive scattering method.
Titt U; Zheng Y; Vassiliev ON; Newhauser WD
Phys Med Biol; 2008 Jan; 53(2):487-504. PubMed ID: 18185001
[TBL] [Abstract][Full Text] [Related]
15. [Proton irradiation of bone metastases].
Monzul' GD; Kondrat'eva AP; Ratner TG; Lisovets SP
Med Radiol (Mosk); 1984 Jun; 29(6):17-20. PubMed ID: 6330488
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric impact of tantalum markers used in the treatment of uveal melanoma with proton beam therapy.
Newhauser WD; Koch NC; Fontenot JD; Rosenthal SJ; S Gombos D; Fitzek MM; Mohan R
Phys Med Biol; 2007 Jul; 52(13):3979-90. PubMed ID: 17664589
[TBL] [Abstract][Full Text] [Related]
17. A beam source model for scanned proton beams.
Kimstrand P; Traneus E; Ahnesjö A; Grusell E; Glimelius B; Tilly N
Phys Med Biol; 2007 Jun; 52(11):3151-68. PubMed ID: 17505095
[TBL] [Abstract][Full Text] [Related]
18. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm.
Newhauser W; Fontenot J; Zheng Y; Polf J; Titt U; Koch N; Zhang X; Mohan R
Phys Med Biol; 2007 Aug; 52(15):4569-84. PubMed ID: 17634651
[TBL] [Abstract][Full Text] [Related]
19. Extended collimator model for pencil-beam dose calculation in proton radiotherapy.
Kanematsu N; Akagi T; Takatani Y; Yonai S; Sakamoto H; Yamashita H
Phys Med Biol; 2006 Oct; 51(19):4807-17. PubMed ID: 16985272
[TBL] [Abstract][Full Text] [Related]
20. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
Hata M; Tokuuye K; Kagei K; Sugahara S; Nakayama H; Fukumitsu N; Hashimoto T; Mizumoto M; Ohara K; Akine Y
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):786-93. PubMed ID: 17379439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
